| Senior HEOR Manager |
Dublin (Country President Office (CPO)) |
Ireland |
International |
Innovative Medicines |
Market Access |
jan 16, 2025 |
| Value & Access Manager |
Bangkok |
Thailand |
International |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| Field Value Access Partner |
Sintra |
Portugal |
International |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| AD, Access & Reimbursement RLT Portland, OR - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| AD, Access & Reimbursement RLT - Remote - Manhattan/Long Island |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| AD, Access & Reimbursement RLT San Francisco, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| Bidding Strategy Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| Bidding Strategy & Market Access Lead |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Market Access |
jan 15, 2025 |
| Value Regional Access Manager |
Vizcaya |
Spain |
International |
Innovative Medicines |
Market Access |
jan 14, 2025 |
| Associate Director, Contracting & Analytics - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 13, 2025 |
| Strategic Partnership lead |
Kista |
Sweden |
International |
Innovative Medicines |
Market Access |
jan 13, 2025 |
| AD, Access & Reimbursement NPS RLT Remote- Houston, TX |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
jan 08, 2025 |
| Market Access Specialist |
Mapletree Business City (MBC) |
Singapore |
International |
Innovative Medicines |
Market Access |
jan 08, 2025 |
| 市场准入经理 |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Market Access |
jan 07, 2025 |
| 市场准入大区经理 |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Market Access |
jan 06, 2025 |
| Sr. HEOR & Access Strategy Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Market Access |
des 19, 2024 |
| Associate Director, Market Access Early Pipeline & BD&L - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
des 16, 2024 |
| Market Access Lead/Senior Lead |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Market Access |
des 15, 2024 |
| HEOR Manager |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
des 05, 2024 |
| Director, US HEOR Product Lead - RLT |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
des 04, 2024 |
| Senior Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Market Access |
des 03, 2024 |
| Associate Director RWE Manager |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Market Access |
des 03, 2024 |
| Innovative Access Partnerships and Engagement Manager |
İstanbul Kavacık |
Türkiye |
International |
Innovative Medicines |
Market Access |
des 03, 2024 |
| Value Access Manager |
Bogota (Oncology) / Cali (Pharmaceuticals) |
Colombia |
International |
Innovative Medicines |
Market Access |
des 03, 2024 |
| Sr. HEOR & Access Strategy Manager |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Market Access |
nov 29, 2024 |
| Solution & Service Design Manager |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
aug 15, 2024 |
| Real World Evidence Research Analyst |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Market Access |
aug 12, 2024 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
apr 16, 2024 |
| Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
apr 16, 2024 |